FDA-Drug2020-05-06Class I
Ceftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex Container, RX only, B Braun Medical Inc., Bethlehem, PA 18018-3524, NDC 0264-3145-11
B. Braun Medical Inc
Hazard
Failed Stability Specifications: Out-of-Specification (OOS) results for High Molecular Weight Polymers.
Sold states
Product was distributed nationwide within the United States.
Affected count
22,488 Duplex containers
Manufactured in
2525 Mcgaw Ave, N/A, Irvine, CA, United States
Products
Ceftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex Container, RX only, B Braun Medical Inc., Bethlehem, PA 18018-3524, NDC 0264-3145-11
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1257-2020Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief